Solicitation

Notice
Q&A

HT942523Q0059: LASSA FEVER VIRUS (LASV) CELL SORTING FOR MONOCLONAL ANTIBODY DISCOVERY FOR USAMRIID - AMENDMENT 0001 - QUESTIONS FROM OFFERORS

Update

Cancel Notice

Notice ID

Solicitation Type

Update Number

Public Posting Link

Response Date

Response Date Time Zone

Set Aside Code

Description

This is a combined synopsis/solicitation for commercial services prepared in accordance with FAR 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice and FAR 13, Simplified Acquisition Procedures. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is HT942523Q0059. The solicitation is issued as a Request for Proposal (RFP). Provisions and clauses in effect through Federal Acquisition Circular 2023-04 are incorporated. It is the contractor’s responsibility to be familiar with the applicable clauses and provisions. The clause may be access in full text at: https://www.acquisition.gov/.The associated North American Industrial Classification System (NAICS) code for this procurement is 541380, with a small business size standard of $19.0M. This action is set-aside 100% for small businesses.The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has a requirement for a contract that provides for severable, non-personal services to sort peripheral blood mononuclear cells (PBMCs) from Lassa fever virus (LASV) survivors to discover and produce monoclonal antibodies for assessment in in-vitro and in-vivo assays at USAMRIID. Successful antibody discovery pipelines depend on: (1) the source sample used for antibody discovery, (2) the availability of high-quality antigens to identify and down-select candidate Monoclonal antibodies (mAbs), and (3) a detailed understanding of the underlying biology of the target. The contract, awarded as a result of this solicitation, will consist of one, 12-month base period and two, 12-month option periods for a total of 36 months.The U.S. Army Medical Research Acquisition Activity (USAMRAA) requests responses from qualified sources capable of providing services outlined in the Performance Work Statement (PWS). Please refer to attached solicitation for additional details and instructions.

Points of Contact

Primary Contact Name

Primary Contact Email

Primary Contact Phone Number

Primary Contact Fax

Update Details

Subject

Posting Date

Archive Date

Product or Service Code

NAICS

Place of Performance Zip Code

Place of Performance Address

Recovery Act

Yes

Contract Information

Contracting Office DoDAAC

Contracting Office Name

Contracting Office Address

808 SCHREIDER ST FORT DETRICK          MD 21702-5014 FORT DETRICK  MD  21702 FORT DETRICK MD 21702 USA

A Material Safety Data Sheet (MSDS) must be attached to offer submissions in accordance with FAR Clause 52.223-3.

Attachments

Name	Number	File/URL	Date	Document Type	Include in Response
Combined_Synopsis_Solicitation_HT942523Q0059_Amend_0001		Combined_Synopsis_Solicitation_HT942523Q0059_Amend_0001.docx	2023-06-29	Attachment	No

Update / Notice

Update / Notice ID	Description	Posted Date	Response Date
HT942523Q0059	This is a combined synopsis/solicitation for commercial services prepared in accordance with FAR 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice an	2023/06/22 15:46 UTC	2023-07-24 13:00 Eastern Daylight Time